A Phase 1 Study of TDM-180935 Following Topical Administration in Healthy Male Subjects

NCT05525468 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: TDM-180935
DRUG: Placebo

Sponsor

Technoderma Medicines Inc.

Collaborators

[object Object]